Industry News
ZIM to Launch ZIM eCommerce Baltimore eXpress (ZXB), a New Speedy eCommerce service from China and South-East Asia to the US East Coast
The New Service Expands ZIM's Speedy Premium Services for eCommerce Customers
HAIFA, Israel, March 14, 2022 /PRNewswire/ -- ZIM Integrated Shipping
Services Ltd.
Parpera & Railspay launch Australia's first embedded finance business debit card
SYDNEY, March 14, 2022 /PRNewswire/ -- Parpera
Fasanara makes key hires as it looks to expand across products and geographies
LONDON, March 14, 2022 /PRNewswire/ -- Encouraged by the increasing interest in its suite of Fintech Investment Products, Fasanara Capital has made two significant additions to the team to strengthen deal origination and support the launch of its new Fintech-focused Venture Capital Fund. The fir...
Giift, backed by Apis Growth Fund II, acquires a majority ownership in Xoxoday, a fintech disruptor in the rewards, incentives, and payout space
SINGAPORE, March 14, 2022 /PRNewswire/ -- Giift, a leading provider of loyalty management solutions around the globe, announced today that it has acquired a majority interest in Xoxoday, anIndia-based fintech disruptor in the rewards, incentives, and payout space. Giift's investment will enable X...
Gefen Releases a New Integrated BI Module
TEL AVIV, Israel, March 14, 2022 /PRNewswire/ -- Gefen
CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer
* GAVRETO is the first and only selective rearranged during transfection (RET) inhibitor approved inChina for the treatment of RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC) * The labeled indications of GAVRETO have been expanded after it was approved by...
Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant
TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that medRxiv, a preprint platform for preliminary biomedical research, published an academic paper1 on the efficacy of CanSinoBIO's Recombinant COVID-19 Vaccine ("Ad5-n...
Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea
SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines
Addibond™ obtains Solar Impulse Efficient Solution Label
BRUSSELS, March 14, 2022 /PRNewswire/ -- Solvay's water-soluble Addibond™
polymer
CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings
SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System
will provide a total of 2,076 units of modular buildings to helpHong Kong fight
against the COVID-19 pandemic.
StashAway launches Accredited Investors access to private equity, venture capital, angel investing and digital assets
SINGAPORE, March 14, 2022 /PRNewswire/ -- StashAway has introduced an offering designed exclusively for Accredited Investors (AIs): StashAway Reserve. With StashAway Reserve, Accredited Investors can now access private equity and venture capital (PE and VC), angel investing deals, invest in digit...
Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year
HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domesti...
Innovative new beauty technology "Cellester" makes V shaped face and beautiful bust possible. The secret to looking young forever revealed.
HONG KONG, March 12, 2022 /PRNewswire/ -- New beauty technology "Cellester
Crowdfunding Campaign of CR-Scan Lizard Coming to an End with Creality's Continuous Trend Leading
SHENZHEN, China, March 12, 2022 /PRNewswire/ -- In February, Creality launched the crowdfunding campaign for 3D scanner - CR-Scan Lizard on Kickstarter. The campaign made a stir among users with 1000 units in 17 minutes, and1 million dollars in 4 hours. Till now, Creality has received more than 2...
Lacework Ranked #6 on Forbes America's Best Startup Employers List
Forbes recognizes Lacework for accelerated growth and strong employee engagement as cloud security sector booms SAN JOSE, Calif., March 12, 2022 /PRNewswire/ -- Lacework, the data-driven security company for the cloud, today announced the company ranked sixth in Forbes' America's Best Startup Em...
Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals
NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals ("Concert") to acquire a portfolio...
Innodisk DDR5 Raises the Bar for Workstations
TAIPEI, March 11, 2022 /PRNewswire/ -- Innodisk has announced the debut of their new industrial-grade DDR5 memory in workstations, which are powerful computers intended for specialized technical and scientific use cases. Bringing this new technology to market now gives early adopters the chance t...
Chery and Haier to jointly build the automotive industry Internet platform
JERUSALEM, March 11, 2022 /PRNewswire/ -- Chery and Haier set up a joint venture - Anhui Haixingyun Iot Technology Co., Ltd. The joint venture will use the COSMOPlat of Haier to build the first mass customization industrial Internet platform inChina's automobile industry and jointly build a new ...
China Matters produced the animated video series 'The 24 Solar Terms in Poetry and Painting'
BEIJING, March 11, 2022 /PRNewswire/ -- China Matters animation team produced the animated video seriesThe 24 Solar Terms in Poetry and Painting, which illustrates the Chinese solar terms through dynamic Chinese paintings and classical poems translated by Dr. Xu Yuanchong. The five solar terms in...
NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC)
SINGAPORE, March 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for SCG101, the company's first T-...
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15